Achieving Health Equity Through Community Engagement in Translating Evidence to Policy: The San Francisco Health Improvement Partnership, 2010-2016.
The San Francisco Health Improvement Partnership (SFHIP) promotes health equity by using a novel collective impact model that blends community engagement with evidence-to-policy translational science. The model involves diverse stakeholders, including ethnic-based community health equity coalitions, the local public health department, hospitals and health systems, a health sciences university, a school district, the faith community, and others sectors.



We report on 3 SFHIP prevention initiatives: reducing consumption of sugar sweetened beverages (SSBs), regulating retail alcohol sales, and eliminating disparities in children's oral health.



SFHIP is governed by a steering committee. Partnership working groups for each initiative collaborate to 1) develop and implement action plans emphasizing feasible, scalable, translational-science-informed interventions and 2) consider sustainability early in the planning process by including policy and structural interventions.



Through SFHIP's efforts, San Francisco enacted ordinances regulating sale and advertising of SSBs and a ballot measure establishing a soda tax. Most San Francisco hospitals implemented or committed to implementing healthy-beverage policies that prohibited serving or selling SSBs. SFHIP helped prevent Starbucks and Taco Bell from receiving alcohol licenses in San Francisco and helped prevent state authorization of sale of powdered alcohol. SFHIP increased the number of primary care clinics providing fluoride varnish at routine well-child visits from 3 to 14 and acquired a state waiver to allow dental clinics to be paid for dental services delivered in schools.



The SFHIP model of collective impact emphasizing community engagement and policy change accomplished many of its intermediate goals to create an environment promoting health and health equity.
Community Engagement and Health Policy Program, Clinical and Translational Science Institute, University of California, San Francisco, California.|Department of Family and Community Medicine, University of California, San Francisco, California.
Kevin
K
Grumbach
Community Engagement and Health Policy Program, Clinical and Translational Science Institute, University of California, San Francisco, California.|Department of Family and Community Medicine, University of California, San Francisco, California.
Roberto A
RA
Vargas
Community Engagement and Health Policy Program, Clinical and Translational Science Institute, University of California, San Francisco, California.|Department of Family and Community Medicine, University of California, San Francisco, California.
Paula
P
Fleisher
San Francisco Department of Public Health, San Francisco, California.
Tomás J
TJ
Aragón
Community Engagement and Health Policy Program, Clinical and Translational Science Institute, University of California, San Francisco, California.|Division of Oral Epidemiology and Public Health, School of Dentistry, University of California, San Francisco, California.
Lisa
L
Chung
San Francisco Department of Public Health, San Francisco, California.
Colleen
C
Chawla
Dignity Health, Saint Francis Memorial Hospital, San Francisco, California.
Abbie
A
Yant
Instituto Familiar de la Raza, Inc., San Francisco, California.|Chicano/Latino/Indígena Health Equity Coalition, San Francisco, California.
Estela R
ER
Garcia
APA Family Support Services, San Francisco, California.|API Health Parity Council, San Francisco, California.
Amor
A
Santiago
Rafiki Wellness, San Francisco, California.|African American Community Health Equity Council, San Francisco, California.
Perry L
PL
Lang
San Francisco Department of Public Health, San Francisco, California.
Paula
P
Jones
Community Engagement and Health Policy Program, Clinical and Translational Science Institute, University of California, San Francisco, California.
Wylie
W
Liu
Community Engagement and Health Policy Program, Clinical and Translational Science Institute, University of California, San Francisco, California.|Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco.
Laura A
LA
Schmidt
D001628:Beverages / Q000706:statistics & numerical data; D003256:Community Participation; D002149:Energy Intake; D000069576:Health Equity; D006291:Health Policy / Q000191:economics / Q000331:legislation & jurisprudence; D006801:Humans; D007294:Inositol / Q000031:analogs & derivatives; D009313:National Health Programs; D009749:Nutrition Surveys; D009909:Oral Health; D012495:San Francisco; D012574:Schools
C477931:1L-6-hydroxymethyl-chiro-inositol 2(R)-2-O-methyl-3-O-octadecylcarbonate; D007294:Inositol